Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Florian Lang & Jakob Voelkl. (2013) Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opinion on Investigational Drugs 22:6, pages 701-714.
Read now
Read now
Madhuri S Salker, Siobhan Quenby & Jan J Brosens. (2012) SGK1: a therapeutic target to prevent reproductive failure?. Expert Review of Obstetrics & Gynecology 7:2, pages 101-104.
Read now
Read now
Articles from other publishers (10)
Nis Halland, Friedemann Schmidt, Tilo Weiss, Ziyu Li, Jörg Czech, Joachim Saas, Danping Ding-Pfennigdorff, Matthias K. Dreyer, Carsten Strübing & Marc Nazare. (2021) Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis. Journal of Medicinal Chemistry 65:2, pages 1567-1584.
Crossref
Crossref
Taj Mohammad & Md. Imtaiyaz Hassan. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
223
238
.
Vincenzo Dattilo, Rosario Amato, Nicola Perrotti & Massimo Gennarelli. (2020) The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms. Frontiers in Genetics 11.
Crossref
Crossref
Ruizhe Zhu, Gang Yang, Zhe Cao, Kexin Shen, Lianfang Zheng, Jianchun Xiao, Lei You & Taiping Zhang. (2020) The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star. Therapeutic Advances in Medical Oncology 12, pages 175883592094094.
Crossref
Crossref
Bashir A. Akhoon, Neha S. Gandhi & Rakesh Pandey. (2019) Computational insights into the active structure of SGK1 and its implication for ligand design. Biochimie 165, pages 57-66.
Crossref
Crossref
Nis Halland, Friedemann Schmidt, Tilo Weiss, Joachim Saas, Ziyu Li, Jörg Czech, Matthias Dreyer, Armin Hofmeister, Katharina Mertsch, Uwe Dietz, Carsten Strübing & Marc Nazare. (2014)
Discovery of
N
-[4-(1
H
-Pyrazolo[3,4-
b
]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors
. ACS Medicinal Chemistry Letters 6:1, pages 73-78.
Crossref
Crossref
Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado & Juan C. Carril. 2014. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
323
556
.
Jakob Voelkl, Yun Lin, Ioana Alesutan, Mohamed Siyabeldin E. Ahmed, Venkanna Pasham, Sobuj Mia, Shuchen Gu, Martina Feger, Ambrish Saxena, Bernhard Metzler, Dietmar Kuhl, Bernd J. Pichler & Florian Lang. (2012) Sgk1 sensitivity of Na+/H+ exchanger activity and cardiac remodeling following pressure overload. Basic Research in Cardiology 107:2.
Crossref
Crossref
Ramón Cacabelos, Rocío Martínez, Lucía Fernández-Novoa, Juan C. Carril, Valter Lombardi, Iván Carrera, Lola Corzo, Iván Tellado, Jerzy Leszek, Adam McKay & Masatoshi Takeda. (2012)
Genomics of Dementia:
APOE
- and
CYP2D6
-Related Pharmacogenetics
. International Journal of Alzheimer's Disease 2012, pages 1-37.
Crossref
Crossref
Ramón Cacabelos, Lucía Fernández-Novoa, Rocío Martínez-Bouza, Adam McKay, Juan C. Carril, Valter Lombardi, Lola Corzo, Iván Carrera, Iván Tellado, Laura Nebril, Margarita Alcaraz, Susana Rodríguez, Ángela Casas, Verónica Couceiro & Antón Álvarez. (2010) Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. Pharmaceuticals 3:10, pages 3040-3100.
Crossref
Crossref